FDA Orange Book
Generic for Vivlodex
Vivlodex contains meloxicam. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Vivlodex is meloxicam. 2 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
Run it in Rivvi
Map Vivlodex and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Vivlodex products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| capsule, oral | 10MG | Discontinued | None | 2 | AB |
| capsule, oral | 5MG | Discontinued | None | 2 | AB |
NDA 207233, held by ICEUTICA OPERATIONS LLC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic meloxicam
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| LUPIN LTD | 209487 | AB (A-rated, therapeutically equivalent) | June 1, 2020 | 10MG, 5MG |
| NOVITIUM PHARMA LLC | 211398 | AB (A-rated, therapeutically equivalent) | March 9, 2021 | 10MG, 5MG |
Vivlodex patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 9526734 | March 31, 2033 | Drug product | None | 207233 |
| 9808468 | March 31, 2035 | Method of use | U-2165 | 207233 |
| 9808468 | March 31, 2035 | Method of use | U-2160 | 207233 |
| 9649318 | March 31, 2035 | Drug product | None | 207233 |
Questions
Is there a generic for Vivlodex?
Yes. The generic name for Vivlodex is meloxicam. 2 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
What is the generic name for Vivlodex?
The active ingredient in Vivlodex is meloxicam, per the FDA Orange Book.
When does the Vivlodex patent expire?
The last patent listed for Vivlodex in the Orange Book expires March 31, 2035. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.